Source: Annual Congress 2013 –Pneumonia and sepsis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Uranga, A. Capelastegui, P. P. Espana, R. Díez, R. Zalacaín, L. A. López, A. Bilbao, M. J. Lopez (Galdakao, Bilbao, Basurto, Spain). Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia. Eur Respir J 2013; 42: Suppl. 57, 296

Member's Comments

No comment yet.

Related content which might interest you: Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Physical deterioration during hospitalization in patients with community-acquired pneumonia Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015 Influence of comorbidities on pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2010; 36: 128-134 Year: 2010 Cost of treatment failure in community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 195s Year: 2007 Mixed community-acquired pneumonia in hospitalised patients Source: Eur Respir J 2006; 27: 795-800 Year: 2006 Modern etiology of severe community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia Source: Eur Respir J 2006 Oct 01;28(4):816-823 Year: 2006 Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia Source: Eur Respir J 2007; 30: 517-524 Year: 2007 Empirical treatment of community-acquired pneumonia after outpatient beta-lactam therapy Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Bacteremic vs. non-bacteremic pneumococcal pneumonia in immunocompetent patients: Predictive and prognostic factors Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Severe community-acquired pneumonia Source: Eur Respir Monogr 2016; 74: 101-116 Year: 2016 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009 Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Bacteraemia in outpatient with community-acquired pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Preventing community-acquired pneumonia Source: International Congress 2019 – Respiratory infections: prevention is better than cure Year: 2019